ArticleThe Journal of clinical investigation2020

Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma.

Byoung-San Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.